학술논문
Genomic heterogeneity at baseline is associated with T790M resistance mutations in EGFR‐mutated lung cancer treated with the first‐/second‐generation tyrosine kinase inhibitors.
Document Type
Article
Author
Menzel, Michael; Kirchner, Martina; Kluck, Klaus; Ball, Markus; Beck, Susanne; Allgäuer, Michael; Assmann, Christin; Schnorbach, Johannes; Volckmar, Anna‐Lena; Tay, Timothy Kwang Yong; Goldschmid, Hannah; Tan, Daniel SW; Thomas, Michael; Kazdal, Daniel; Budczies, Jan; Stenzinger, Albrecht; Christopoulos, Petros
Source
Journal of Pathology: Clinical Research; Mar2024, Vol. 10 Issue 2, p1-10, 10p
Subject
Language
ISSN
20564538
Abstract
Copyright of Journal of Pathology: Clinical Research is the property of Wiley-Blackwell and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)